Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The "Implantable Defibrillators Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
The global implanted defibrillator market is expected to grow from $5.26 billion in 2022 to $5.46 billion in 2023 at a compound annual growth rate (CAGR) of 5.85%. The implanted defibrillator market is expected to reach $6.45 billion in 2027 at a CAGR of 4.24%.
The implantable defibrillators market research report provides implantable defibrillators market statistics, including implantable defibrillators industry global market size, regional shares, competitors with a implantable defibrillators market share, detailed implantable defibrillators market segments, market trends and opportunities, and any further data you may need to thrive in the implantable defibrillators industry.
The implantable defibrillators market is experiencing substantial growth due to the increasing prevalence of sudden cardiac arrest (SCA). SCA is a condition characterized by the unexpected cessation of heart function, and implantable defibrillators play a vital role in providing life-saving therapy by detecting and correcting abnormal heart rhythms that can lead to SCA.
A report published by the Journal of the American College of Cardiology revealed that SCD (Sudden Cardiac Death) causes between 185,000 to 450,000 deaths annually in the US population, accounting for 7% to 18% of all fatalities. The growing incidence of sudden cardiac arrest is a major driving force behind the expansion of the implantable defibrillators market.
Technological advancements are a prominent trend in the implantable defibrillators market, with leading companies actively focusing on innovation to remain competitive. For instance, in July 2020, Abbott, a US-based healthcare company specializing in cardiovascular devices, introduced Gallant ICD and CRT devices equipped with Bluetooth connectivity and continuous remote monitoring capabilities.
These devices are distinguished by their extended battery life, MRI compatibility, Bluetooth technology, and a patient smartphone app for enhanced remote monitoring. Patients with Gallant devices can receive real-time updates about their heart health, while healthcare providers can monitor their condition remotely.
The Gallant devices incorporate advanced algorithms for detecting abnormal heart rhythms and delivering appropriate therapy. Bluetooth connectivity allows patients to sync their devices with their smartphones, enabling the transmission of vital data to healthcare providers for analysis.
In December 2022, Johnson & Johnson Services Inc., a US-based healthcare product manufacturer, acquired Abiomed for $16.6 billion. This acquisition expanded Johnson & Johnson's MedTech portfolio, adding heart recovery technologies to its globally renowned Biosense Webster electrophysiology business, enhancing its presence in the rapidly growing cardiovascular sector. Abiomed is a US-based provider of cardiovascular medical technology, including implantable defibrillators.
North America emerged as the largest region in the implantable defibrillators market in 2022, with Asia-Pacific projected to witness the fastest growth in the forecast period. The implantable defibrillators market report covers several countries, including Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.
Key Attributes:
Report Attribute | Details |
No. of Pages | 275 |
Forecast Period | 2023 - 2027 |
Estimated Market Value (USD) in 2023 | $5.46 billion |
Forecasted Market Value (USD) by 2027 | $6.45 billion |
Compound Annual Growth Rate | 4.3% |
Regions Covered | Global |
Major players in the implantable defibrillators market are
- Boston Scientific Corporation
- LivaNova Plc
- Biotronik Se & Co.KG
- MicroPort Scientific Corporation
- Mayo Clinic
- Medtronic
- St. Jude Medical Inc.
- Abbott Laboratories
- Sorin Medical Group
- Nihon Kohden Corporation
- Koninklijke Philips N.V.
- Fukuda Denshi
- Stryker
- LivaNova PLC
- Progetti Srl
Key Topics Covered:
1. Executive Summary
2. Implantable Defibrillators Market Characteristics
3. Implantable Defibrillators Market Trends And Strategies
4. Implantable Defibrillators Market - Macro Economic Scenario
4.1. COVID-19 Impact On Implantable Defibrillators Market
4.2. Ukraine-Russia War Impact On Implantable Defibrillators Market
4.3. Impact Of High Inflation On Implantable Defibrillators Market
5. Implantable Defibrillators Market Size And Growth
5.1. Global Implantable Defibrillators Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Implantable Defibrillators Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Implantable Defibrillators Market Segmentation
6.1. Global Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Single Chambered Implantable Defibrillators
- Dual Chambered Implantable Defibrillators
- Biventricular Implantable Defibrillators
6.2. Global Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Trans-Venous Implantable Defibrillators
- Subcutaneous Implantable Defibrillators
6.3. Global Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Hospitals And Clinics
- Ambulatory Surgery Centers
- Other End Users
7. Implantable Defibrillators Market Regional And Country Analysis
7.1. Global Implantable Defibrillators Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Implantable Defibrillators Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/de1hfh
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment